CeriBell (CBLL) News Today $20.16 -0.89 (-4.23%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Emerald Advisers LLC Buys New Stake in CeriBell (NASDAQ:CBLL)Emerald Advisers LLC purchased a new stake in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 120,805 shares of the company's stock, valued at approximately $3,126,000. EmeraldMarch 25 at 5:45 AM | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Gap Up - Time to Buy?CeriBell (NASDAQ:CBLL) Shares Gap Up - Still a Buy?March 18, 2025 | marketbeat.comCeribell executives receive pay increases and incentivesMarch 16, 2025 | uk.investing.comCeriBell (NASDAQ:CBLL) Stock Price Down 5.7% - Here's WhyCeriBell (NASDAQ:CBLL) Trading Down 5.7% - Here's WhyMarch 13, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Receives Average Rating of "Buy" from BrokeragesCeriBell (NASDAQ:CBLL - Get Free Report) has earned an average recommendation of "Buy" from the six brokerages that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that haMarch 10, 2025 | marketbeat.comRhumbline Advisers Makes New Investment in CeriBell (NASDAQ:CBLL)Rhumbline Advisers bought a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 12,353 shares of the company's stock, valued at approximately $320,000. Analyst Upgrades and DowngradesSeveral broMarch 10, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Up 4.9% - Still a Buy?CeriBell (NASDAQ:CBLL) Trading Up 4.9% - Should You Buy?March 4, 2025 | marketbeat.comCeriBell, Inc. (CBLL) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comWilliam Blair Has Negative Forecast for CeriBell Q1 EarningsCeriBell (NASDAQ:CBLL - Free Report) - William Blair decreased their Q1 2025 earnings per share estimates for CeriBell in a report released on Wednesday, February 26th. William Blair analyst M. Andrew now expects that the company will post earnings of ($0.44) per share for the quarter, down fromMarch 1, 2025 | marketbeat.comCanaccord Genuity Group Reaffirms Buy Rating for CeriBell (NASDAQ:CBLL)Canaccord Genuity Group reaffirmed a "buy" rating and set a $33.00 target price on shares of CeriBell in a research note on Wednesday.February 27, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPSCeriBell (NASDAQ:CBLL - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.08).February 26, 2025 | marketbeat.comCeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ...February 26, 2025 | gurufocus.comQ4 2024 CeriBell Inc Earnings Call TranscriptFebruary 26, 2025 | gurufocus.comCeribell Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | globenewswire.comCeriBell (NASDAQ:CBLL) Shares Up 5.7% - Here's WhyCeriBell (NASDAQ:CBLL) Shares Up 5.7% - Here's WhyFebruary 22, 2025 | marketbeat.comCeriBell: A Leader In AI-Powered Seizure DetectionFebruary 21, 2025 | seekingalpha.comCeriBell (CBLL) to Release Earnings on TuesdayCeriBell (NASDAQ:CBLL) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comCeribell to Participate in the 45th Annual TD Cowen Healthcare ConferenceFebruary 18, 2025 | globenewswire.comCeriBell (NASDAQ:CBLL) Receives Consensus Rating of "Buy" from BrokeragesShares of CeriBell (NASDAQ:CBLL - Get Free Report) have received an average rating of "Buy" from the six research firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have coFebruary 13, 2025 | marketbeat.comCeribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025February 11, 2025 | globenewswire.comCeriBell (CBLL) Projected to Post Earnings on TuesdayCeriBell (NASDAQ:CBLL) will be releasing earnings before the market opens on Tuesday, February 11, Financial Modeling Prep reports.February 4, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading 9.1% Higher - Should You Buy?CeriBell (NASDAQ:CBLL) Trading 9.1% Higher - Still a Buy?January 21, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Given Average Rating of "Buy" by AnalystsShares of CeriBell (NASDAQ:CBLL - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective amonJanuary 19, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 52-Week Low - Time to Sell?CeriBell (NASDAQ:CBLL) Hits New 12-Month Low - What's Next?January 13, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading Down 9.2% - Here's WhyCeriBell (NASDAQ:CBLL) Shares Down 9.2% - Here's What HappenedJanuary 10, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 52-Week Low - Here's WhyCeriBell (NASDAQ:CBLL) Reaches New 52-Week Low - Here's What HappenedJanuary 6, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading Down 3.3% - What's Next?CeriBell (NASDAQ:CBLL) Trading Down 3.3% - What's Next?January 3, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Down 2.6% - Should You Sell?CeriBell (NASDAQ:CBLL) Trading Down 2.6% - Here's What HappenedDecember 26, 2024 | marketbeat.comCeriBell (NASDAQ:CBLL) Receives Consensus Recommendation of "Buy" from AnalystsCeriBell (NASDAQ:CBLL - Get Free Report) has been given an average recommendation of "Buy" by the six research firms that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1 year price target among brokersDecember 25, 2024 | marketbeat.comCeribell to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comCeribell price target raised to $33 from $31 at CanaccordDecember 11, 2024 | markets.businessinsider.comCeribell price target raised to $36 from $31 at TD CowenDecember 11, 2024 | markets.businessinsider.comCeribell, Inc. Set for Growth: Buy Rating Affirmed with Raised Price Target to $36December 9, 2024 | markets.businessinsider.comCeriBell (NASDAQ:CBLL) Given Consensus Recommendation of "Buy" by AnalystsCeriBell (NASDAQ:CBLL - Get Free Report) has been given an average rating of "Buy" by the six ratings firms that are presently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued a reportNovember 30, 2024 | marketbeat.comCeriBell, Inc. (CBLL)November 28, 2024 | finance.yahoo.comCeribell’s Strategic Growth Potential: A Buy Rating Backed by Strong Financials and Competitive EdgeNovember 23, 2024 | markets.businessinsider.comCeriBell: Healthcare Technology Stock With A Promising Growth OutlookNovember 20, 2024 | seekingalpha.comCeribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of MarketingNovember 19, 2024 | markets.businessinsider.comCeribell appoints Rodenbush as CPO, Price as SVP of MarketingNovember 19, 2024 | markets.businessinsider.comFY2024 EPS Estimates for CeriBell Decreased by William BlairCeriBell (NASDAQ:CBLL - Free Report) - Analysts at William Blair decreased their FY2024 earnings estimates for CeriBell in a research note issued to investors on Wednesday, November 13th. William Blair analyst M. Andrew now forecasts that the company will earn ($3.07) per share for the year, downNovember 18, 2024 | marketbeat.comWilliam Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL)CeriBell (NASDAQ:CBLL - Free Report) - Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of CeriBell in a research note issued on Wednesday, November 13th. William Blair analyst M. Andrew expects that the company will post earnings of (November 15, 2024 | marketbeat.comCeribell Inc.’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy RecommendationNovember 14, 2024 | markets.businessinsider.comCeribell price target raised to $31 from $30 at CanaccordNovember 14, 2024 | markets.businessinsider.comCeribell Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comCeribell, Inc. Reports Strong Q3 2024 GrowthNovember 14, 2024 | markets.businessinsider.comCanaccord Genuity Group Issues Positive Forecast for CeriBell (NASDAQ:CBLL) Stock PriceCanaccord Genuity Group increased their target price on shares of CeriBell from $30.00 to $31.00 and gave the company a "buy" rating in a research note on Wednesday.November 13, 2024 | marketbeat.comCeriBell's Quiet Period To End on November 20th (NASDAQ:CBLL)CeriBell's (NASDAQ:CBLL - Get Free Report) quiet period will end on Wednesday, November 20th. CeriBell had issued 10,606,060 shares in its initial public offering on October 11th. The total size of the offering was $180,303,020 based on an initial share price of $17.00. During CeriBell's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.November 13, 2024 | marketbeat.comCeribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 7, 2024 | globenewswire.comCeriBell: An Interesting EEG Play Going PublicOctober 21, 2024 | seekingalpha.com Remove Ads Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address CBLL Media Mentions By Week CBLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBLL News Sentiment▼1.840.79▲Average Medical News Sentiment CBLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBLL Articles This Week▼22▲CBLL Articles Average Week Remove Ads Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Envista News TransMedics Group News Soleno Therapeutics News Enovis News LivaNova News NovoCure News Warby Parker News LeMaitre Vascular News CONMED News Tandem Diabetes Care News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBLL) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts